Article Text

Download PDFPDF

Frailty measurement and outcomes in interventional studies: protocol for a systematic review of randomised control trials
  1. Melissa Shears1,
  2. Danielle McGolrick2,
  3. Braden Waters3,
  4. Marnie Jakab1,
  5. J. Gordon Boyd2,
  6. John Muscedere2
  1. 1School of Medicine, Queen’s University, Kingston, Ontario, Canada
  2. 2Department of Critical Care Medicine, Queen’s University, Kingston, Ontario, Canada
  3. 3Division of Critical Care Medicine, McMaster University, Hamilton, Ontario, Canada
  1. Correspondence to Dr John Muscedere; muscedej{at}kgh.kari.net

Abstract

Introduction Frailty is associated with reduced functional capacity, decreased resistance to stressors and is predictive of a range of adverse health outcomes, including dependency, hospitalisation and mortality. Early identification of frailty may prevent, reduce and postpone adverse health outcomes. However, there is a need for additional evidence to guide decision-making for the care of frail patients since frail persons are frequently excluded from studies, the differential impact of frailty is often not examined in clinical trials and few large-scale clinical trials examining frail cohorts have been conducted. Randomised control trials (RCTs) published to date have used a diverse range of definitions of frailty, as well as a variety of outcome measures. The objective of this systematic review is to comprehensively characterise the frail populations enrolled and the end points reported in frailty RCTs.

Methods and analysis We will identify all RCTs reporting on the outcome of interventions in adult (age ≥18 years) frail populations as defined by authors, in all settings of care. Databases will include MEDLINE, CINAHL, EMBASE, PsycInfo, Global Health, the Joanna Briggs database and Cochrane Library. Two reviewers will independently determine trial eligibility. For each included trial, we will conduct duplicate independent data extraction, inter-rater reliability, risk of bias assessment and evaluation of the quality of the evidence using the Grading of Recommendations, Assessment, Development and Evaluations approach.

Ethics and dissemination This systematic review will comprehensively identify RCTs including frail patients to identify how frailty is measured and which outcomes are reported. The results of this systematic review may inform clinicians caring for persons with frailty, facilitate conduct of future RCTs and inform future efforts to develop common data elements and core outcomes for frailty studies. Our findings will be disseminated through conference presentation and publication in peer-reviewed journals.

PROSPERO registration number CRD42017065233.

  • general medicine (see internal medicine)
  • primary care
  • geriatric medicine

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors JM conceived the idea for this systematic review. JM, MS and DM developed the methodology for the systematic review protocol. The manuscript was drafted by MS and revised by DM, BW, MJ, JGB and JM. JM and DM developed the search strategy. MS, DM, BW, MJ, JGB and JM will screen potential studies and MS and DM will perform full text review. Conflicts will be resolved by JM. MS, DM, BW, MJ, JGB and JM will perform duplicate independent data extraction, risk of bias assessment, GRADE assessment and data synthesis. JM is the guarantor of the review.

  • Funding This study was facilitated and funded by the Canadian Frailty Network (CFN) which is a non-for-profit organisation funded by the government of Canada through the Networks of Centres of Excellence (NCE) programme. CFN had no role in the conduct, analysis or reporting of the study.

  • Competing interests JM is the Scientific Director for the Canadian Frailty Network.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.